Reversal of P-glycoprotein mediated multidrug resistance by novel anthranilamide derivatives

被引:148
|
作者
Roe, M [1 ]
Folkes, A [1 ]
Ashworth, P [1 ]
Brumwell, J [1 ]
Chima, L [1 ]
Hunjan, S [1 ]
Pretswell, I [1 ]
Dangerfield, W [1 ]
Ryder, H [1 ]
Charlton, P [1 ]
机构
[1] Xenova Ltd, Slough SL1 4EF, Berks, England
关键词
D O I
10.1016/S0960-894X(99)00030-X
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have synthesised and evaluated a series of anthranilamide based modulators of P-glycoprotein. These studies have identified XR9576(2), a potent inhibitor of P-glycoprotein in vitro and in vivo. The general synthesis and the SAR of these compounds are described. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:595 / 600
页数:6
相关论文
共 50 条
  • [1] Reversal of P-glycoprotein mediated multidrug resistance by Cryptotanshinone and Dihydrotanshinone
    Hu, Tao
    Yeung, John H. K.
    Wang, Lin
    Zhou, Xuelin
    Or, Penelope M. Y.
    To, Kenneth K. W.
    Cho, Chi Hin
    FASEB JOURNAL, 2013, 27
  • [2] Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives
    Hayashi, M
    Koike, K
    Rho, MC
    Kuwano, M
    Kishiye, T
    Komiyama, K
    ANTI-CANCER DRUG DESIGN, 2001, 16 (4-5): : 255 - 260
  • [3] Inhibition of P-Glycoprotein Mediated Multidrug Resistance by Stemofoline Derivatives
    Umsumarng, Sonthaya
    Pintha, Komsak
    Pitchakarn, Pornsiri
    Sastraruji, Kwankamol
    Sastraruji, Thanapat
    Ung, Alison T.
    Jatisatienr, Araya
    Pyne, Stephen G.
    Limtrakul, Pornngarm
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2013, 61 (04) : 399 - 404
  • [4] Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein
    Laiolo, Jeronimo
    Graikioti, Dafni G.
    Barbieri, Cecilia L.
    Joray, Mariana B.
    Antoniou, Antonia I.
    Vera, D. Mariano A.
    Athanassopoulos, Constantinos M.
    Carpinella, Maria C.
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [5] Novel betulin derivatives as multidrug reversal agents targeting P-glycoprotein
    Jerónimo Laiolo
    Dafni G. Graikioti
    Cecilia L. Barbieri
    Mariana B. Joray
    Antonia I. Antoniou
    D. Mariano A. Vera
    Constantinos M. Athanassopoulos
    María C. Carpinella
    Scientific Reports, 14
  • [6] Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents
    Chen, Chien-Yu
    Liu, Nai-Yu
    Lin, Hui-Chang
    Lee, Chih-Yu
    Hung, Chin-Chuan
    Chang, Chih-Shiang
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 118 : 219 - 229
  • [7] NOVEL STRATEGIES AGAINST MULTIDRUG RESISTANCE MEDIATED BY P-GLYCOPROTEIN
    Casco, S.
    Soto-Vega, E.
    DRUGS OF THE FUTURE, 2016, 41 (03) : 169 - 175
  • [8] Identification of Novel Inhibitors of P-glycoprotein Mediated Multidrug Resistance
    Follit, Courtney A.
    McCormick, James W.
    Nanayakkara, Amila K.
    Wise, John G.
    Vogel, Pia D.
    FASEB JOURNAL, 2017, 31
  • [9] Reversal of P-glycoprotein mediated multidrug resistance in vivo by XR9576
    Mistry, P
    Bootie, D
    Liddle, C
    Loi, R
    Templeton, D
    ANNALS OF ONCOLOGY, 1998, 9 : 148 - 148
  • [10] Reversal of multidrug resistance by novel inhibitors of human P-glycoprotein in cell culture
    Follit, Courtney
    Brewer, Fran
    Vogel, Pia
    Wise, John
    FASEB JOURNAL, 2014, 28 (01):